StockData
CalciMedica, Inc. logo

CalciMedica, Inc. (CALC) shareholders

CALCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 10, 2026Score 2/30
$1.21−0.01 (-0.82%)

Close on Nov 13, 2026Market cap $8.34MP/E –Yield –

Ownership

Institutional holdings as of Jun 30, 2026, from 13F filings

Held by institutions
4.9%
2M of 34M shares
Institutional holders
31
10 new, 6 sold out
Net institutional buying
1M
In Q2 2026
Insider trades, 12 months
1 buys · 0 sales
Net bought $199.18K

Shares held by institutions

Holders of more than 5%

Latest Schedule 13D (active) or 13G (passive) filed by each holder

HolderShares% of classFilingAs of
Alafi Capital Company LLC
Joint filing with Christopher D. Alafi (19.90%)
7,220,10119.90%13D (active) amendmentAug 19, 2026
Bering Partners II GP, L.L.C.
Joint filing with Bering Partners II, L.P. (9.99%), Evgeny Zaytsev (9.99%) and 1 more
3,553,3989.99%13D (active) amendmentAug 19, 2026
Steven Boyd
Joint filing with Armistice Capital, LLC (9.99%)
3,411,3619.99%13G (passive)Jun 30, 2026
Fred A. Middleton
Joint filing with Timothy C. Mills (17.90%), Sanderling Ventures Partners VI, L.P. (7.10%) and 1 more
2,550,55018.30%13D (active)Mar 20, 2023
Woodline Partners LP2,489,7298.10%13G (passive)Jun 30, 2026
Jon M. Plexico
Joint filing with Stonepine Capital Management, LLC (6.00%), Stonepine Capital, L.P. (6.00%) and 1 more
2,149,5226.00%13G (passive)Aug 19, 2026
Philip M Sawyer
Joint filing with Bering Partners II GP, L.L.C. (6.90%), Bering Partners II, L.P. (6.90%) and 1 more
2,113,5136.90%13D (active)Jun 25, 2026
Eric W. Roberts
Joint filing with A. Rachel Leheny (6.30%)
1,965,9166.40%13D (active) amendmentJun 25, 2026
Alafi Capital Company, LLC
Joint filing with Christopher D. Alafi (11.30%)
1,583,15311.30%13G (passive) amendmentJul 22, 2025
CVI Investments, Inc.
Joint filing with Heights Capital Management, Inc. (5.10%)
1,556,0815.10%13G (passive)Jun 23, 2026
Avenue Venture Opportunities Fund II, L.P.
Joint filing with Avenue Capital Management II, L.P. (8.87%), Avenue Venture Opportunities Partners II, LLC (8.87%) and 2 more
1,359,5538.87%13G (passive) amendmentSep 1, 2025
Avenue Capital Management II, L.P.
Joint filing with Avenue Venture Opportunities Fund II, L.P. (8.87%), Avenue Venture Opportunities Partners II, LLC (8.87%) and 2 more
1,359,5538.87%13G (passive) amendmentSep 1, 2025
Guy Levy
Joint filing with Soleus Capital Management, L.P. (7.50%), Soleus GP, LLC (7.50%)
1,075,8567.50%13G (passive) amendmentSep 30, 2025
Philip Sawyer ("Sawyer")
Joint filing with Bering Partners II, L.P. ("Bering II") (5.80%), Bering Partners II GP, L.L.C. ("Bering II GP") (5.80%) and 1 more
663,2465.80%13G (passive)Jan 23, 2024

Top institutional holders

13F holdings as of Jun 30, 2026

HolderShares% of CALCValueChange% of portfolio
Woodline Partners LP497,9461.46%$2.56MNew0.01%
Heights Capital Management, Inc311,2160.91%$1.60MNew0.37%
Squadron Capital Management LLC248,9730.73%$1.28MNew0.40%
Stempoint Capital LP248,9730.73%$1.20MNew0.21%
Stonepine Capital Management, LLC124,4860.36%$544.94KNew0.31%
L1 Global Manager Pty Ltd49,7940.15%$256.44KNew0.18%
Morgan Stanley28,6490.08%$147.54KNew0.00%
Cambridge Investment Research Advisors, Inc.24,0000.07%$124.00K+12,0000.00%
Geode Capital Management, LLC22,0950.06%$113.85K−2,5810.00%
Renaissance Technologies LLC19,4600.06%$100.22K−6,1550.00%
Vanguard Capital Management LLC17,7910.05%$91.63K−16,0310.00%
180 Wealth Advisors, LLC16,6800.05%$85.90K−8,6200.01%
XTX Topco Ltd15,6580.05%$80.64KNew0.00%
Hrt Financial LP9,3650.03%$48.00K+1,4250.00%
Vanguard Fiduciary Trust Co9,1660.03%$47.20K–0.00%
Susquehanna International Group, Llp8,7940.03%$45.29K+2,6510.00%
Rockefeller Capital Management L.P.4,0000.01%$20.60K+3,0000.00%
Gsa Capital Partners Llp3,4940.01%$18.00K−1,2610.00%
State Street Corp3,4150.01%$17.59K–0.00%
TritonPoint Partners, LLC3,0240.01%$15.57K–0.00%

Institutional buying and selling by quarter

Positions opened, added to, reduced and closed by 13F filers

QuarterHoldersShares held% of sharesNew / addedReduced / closedShares boughtShares sold
Q2 2026312M4.9%10 / 56 / 62M0M
Q1 2026270M0.6%11 / 45 / 130M1M
Q4 2025311M2.2%7 / 58 / 60M0M
Q3 2025311M2.1%7 / 410 / 60M0M
Q2 2025301M2.2%4 / 103 / 40M0M
Q1 2025301M2.3%4 / 75 / 30M0M
Q4 2024291M2.5%10 / 83 / 50M0M
Q3 2024241M1.8%6 / 53 / 20M0M
Q2 2024211M1.7%6 / 35 / 50M0M
Q1 2024201M2.1%9 / 60 / 11M0M
Q4 2023120M0.3%0 / 51 / 10M0M
Q3 2023130M0.4%3 / 31 / 30M0M

Officers, directors and major owners

People who filed Forms 3, 4 or 5 in the last two years

NameRoleShares owned% of sharesLatest filing
Eric W. RobertsCHIEF BUSINESS OFFICER, Director1,250,4663.66%Nov 5, 2026
A. Rachel LehenyCHIEF EXECUTIVE OFFICER, Director1,061,4813.11%Sep 28, 2026
Sudarshan HebbarChief Medical Officer186,0250.54%Sep 28, 2026
Kenneth A. StaudermanChief Scientific Officer12,9440.04%Sep 28, 2026
Stephen BardinChief Financial Officer43,0000.13%Sep 28, 2026
Michael J. DunnPresident and COO11,7610.03%Apr 7, 2026
Frederic GuerardDirector111,1100.33%Oct 5, 2026
Allan ShawDirector––Oct 5, 2026
Alan GlicklichDirector––Oct 5, 2026
Robert N. WilsonDirector1,604,6504.70%Oct 5, 2026
Evgeny ZaytsevDirector2,113,5136.19%Oct 5, 2026
Fred A. MiddletonDirector, 10% owner2,700,8347.91%Jun 29, 2026
Capital Co Llc Alafi10% owner5,112,34514.97%Aug 24, 2026

Insider trades

Common stock transactions reported on Form 4, newest first

InsiderDateTransactionSharesPriceValueShares after
A. Rachel Leheny
CHIEF EXECUTIVE OFFICER, Director, 10% owner
Jun 25, 2026Award+186,729$0.80$149.38K317,655
Fred A. Middleton
Director, 10% owner
Jun 25, 2026Buy+248,972$0.80$199.18K1,063,272
Sudarshan Hebbar
Chief Medical Officer
Jun 25, 2026Award+124,486$0.80$99.59K186,025
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 25, 2026Award+186,729$0.80$149.38K366,435
Robert N. Wilson
Director
Jun 25, 2026Award+1,182,621$0.80$946.10K1,604,650
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Sep 18, 2025Buy+2,500$3.07$7.68K84,150
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Sep 15, 2025Buy+3,400$2.68$9.11K81,650
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Sep 12, 2025Buy+5,000$3.12$15.60K78,250
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Sep 9, 2025Buy+2,343$3.15$7.38K73,250
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 29, 2025Buy+800$2.74$2.19K70,907
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 28, 2025Buy+9,200$2.86$26.31K70,107
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 21, 2025Buy+3,508$2.79$9.79K60,907
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 20, 2025Buy+2,000$2.72$5.44K57,399
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 20, 2025Option exercise+15,000$1.53$22.95K179,706
Sudarshan Hebbar
Chief Medical Officer
Aug 19, 2025Buy+9,563$2.82$26.97K61,539
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 19, 2025Buy+1,000$2.79$2.79K55,399
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 15, 2025Buy+5,076$2.90$14.72K54,399
Sudarshan Hebbar
Chief Medical Officer
Aug 15, 2025Buy+4,392$2.79$12.25K51,976
Sudarshan Hebbar
Chief Medical Officer
Aug 14, 2025Buy+1,584$2.59$4.10K47,584
Kenneth A. Stauderman
Chief Scientific Officer
Jul 28, 2025Buy+1,000$3.96$3.96K12,944
Kenneth A. Stauderman
Chief Scientific Officer
Jul 25, 2025Sale−1,000$3.65$3.65K0
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jul 22, 2025Buy+1,500$3.78$5.67K49,323
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jul 21, 2025Buy+1,500$3.37$5.06K47,823
A. Rachel Leheny
CHIEF EXECUTIVE OFFICER, Director, 10% owner
Jul 21, 2025Buy+1,000$3.40$3.40K3,500
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jul 18, 2025Buy+2,000$2.88$5.76K46,323
Robert N. Wilson
Director
Jul 18, 2025Buy+4,500$2.87$12.92K422,029
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jul 14, 2025Buy+6,500$2.43$15.80K44,323
A. Rachel Leheny
CHIEF EXECUTIVE OFFICER, Director, 10% owner
Jul 14, 2025Buy+2,500$2.47$6.18K2,500
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jul 9, 2025Buy+5,000$1.60$8.00K37,823
Kenneth A. Stauderman
Chief Scientific Officer
Jul 1, 2025Buy+1,000$1.85$1.85K1,000
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 26, 2025Buy+4,500$1.44$6.48K32,823
Stephen Bardin
Chief Financial Officer
Jun 26, 2025Buy+2,000$1.50$3.00K3,000
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 11, 2025Buy+5,000$1.85$9.25K28,323
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 6, 2025Buy+5,000$1.78$8.90K23,323
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 5, 2025Buy+5,100$1.70$8.67K18,323
Stephen Bardin
Chief Financial Officer
May 30, 2025Buy+1,000$1.69$1.69K41,000
Fred A. Middleton
Director, 10% owner
Dec 6, 2024Buy+4,800$2.65$12.72K36,514
Fred A. Middleton
Director, 10% owner
Nov 1, 2024Buy+877$3.75$3.29K22,479
Fred A. Middleton
Director, 10% owner
Nov 1, 2024Buy+86,867$3.75$325.75K814,300
Fred A. Middleton
Director, 10% owner
Nov 1, 2024Buy+20,000$3.75$75.00K31,714
Venture Partners VI LP Sanderling
10% owner
Nov 1, 2024Buy+86,867$3.75$325.75K814,300
Venture Partners VI LP Sanderling
10% owner
Nov 1, 2024Buy+877$3.75$3.29K22,479
Robert N. Wilson
Director
Nov 1, 2024Buy+53,333$3.75$200.00K417,529
A. Rachel Leheny
CHIEF EXECUTIVE OFFICER, Director, 10% owner
Nov 1, 2024Buy+20,000$3.75$75.00K130,926
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Nov 1, 2024Buy+53,333$3.75$200.00K164,706
Michael J. Dunn
President and COO
Sep 9, 2024Option exercise+11,761$1.39$16.35K11,761
A. Rachel Leheny
CHIEF EXECUTIVE OFFICER, Director, 10% owner
Aug 27, 2024Buy+1,000$4.19$4.19K110,926
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 23, 2024Buy+3,000$3.57$10.71K13,223
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 23, 2024Buy+2,000$3.58$7.16K46,894
Robert N. Wilson
Director
Aug 23, 2024Buy+54,000$3.72$200.88K364,196
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Aug 21, 2024Buy+5,000$4.04$20.20K44,894
Robert N. Wilson
Director
Jun 28, 2024Buy+51,278$3.52$180.50K310,196
Robert N. Wilson
Director
Jun 27, 2024Buy+8,443$3.23$27.27K258,918
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Jun 27, 2024Buy+5,000$3.22$16.10K10,223
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Apr 2, 2024Buy+3,254$3.90$12.69K39,894
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Apr 1, 2024Buy+746$3.90$2.91K36,640
Eric W. Roberts
CHIEF BUSINESS OFFICER, Director, 10% owner
Feb 5, 2024Award+91,086$4.27$388.94K111,373
Venture Partners VI LP Sanderling
10% owner
Jan 23, 2024Buy+144,676$3.70$535.30K727,433
Venture Partners VI LP Sanderling
10% owner
Jan 23, 2024Buy+243,356$3.70$900.42K946,744
Venture Partners VI LP Sanderling
10% owner
Jan 23, 2024Buy+194,472$3.70$719.55K435,148

Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.

Short interest

Shares sold short and not yet bought back, as of Oct 30, 2026 (FINRA, reported twice a month)

Short % of shares outstanding
2.49%
0M shares short
Days to cover
1.8
At 0M shares a day
Change since last report
+178.0%
From 0M shares
Short volume, 20 days
54.9%
Of volume reported to FINRA

Shares sold short, last 12 months

Short sale volume counts trades marked short on any given day, including market-maker hedging, so it runs far higher than the share of CalciMedica's stock actually held short. Settlement fails (shares not delivered on time) peaked at 94,855 shares on Aug 31, 2026 over the last 90 days.

See a number that looks wrong?